Effect of stereotactic implantation of biodegradable 5-fluorouracil- loaded microspheres in healthy and C6 glioma-bearing rats

Neurosurgery

Volumn 39, Issue 1, 1996, Pages 117-124

  Menei, Philippe ^a   Boisdron Celle, Michèle ^b   Croué, Anne ^a   Guy, Gilles ^a   Benoit, Jean Pierre ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

Author keywords

5 Fluorouracil; Drug delivery; Malignant glioma; Microspheres; Poly(lactic acid co glycolic acid); Stereotaxy

Indexed keywords

FLUOROURACIL; MICROSPHERE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CANCER CHEMOTHERAPY; DRUG COMBINATION; DRUG DELIVERY SYSTEM; FEMALE; GLIOMA; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTAXIC SURGERY;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BIODEGRADATION, ENVIRONMENTAL; BRAIN; BRAIN NEOPLASMS; DRUG IMPLANTS; FEMALE; FLUOROURACIL; GLIOMA; MICROSPHERES; NEOPLASM TRANSPLANTATION; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; STEREOTAXIC TECHNIQUES; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0030003395     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199607000-00023     Document Type: Article

References (40)

1. Aoki N: Reversible leukoencephalopathy caused by 5-fluorouracil derivatives, presenting as akinetic mutism. Surg Neurol 25:279-282, 1986.
2. Barker M, Hoshino T, Garcay O, Wilson CB, Nielsen SL, Downie R: Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 33:976-986, 1973.
3. Benda P, Lightbody J, Sato G, Levine L, Sweet W: Differentiated rat glial cell strain in tissue culture. Science 161:370-371, 1968.
4. Benita S, Benoit JP, Puisieux F, Thies C: Characterization of drug-loaded poly(D,L-lactide) microspheres. J Pharm Sci 73:1721-1724, 1984.
5. Bernstein JJ, Goldberg WJ, Laws ER Jr, Conger DC, Morreale V, Woods LR: C6 glioma cell invasion and migration of rat brain after neural homografting: Ultrastructure. Neurosurgery 26:622-628, 1990.
6. Boisdron-Celle M, Menei P, Benoit JP: Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. J Pharm Pharmacol 47:108-114, 1995.
7. Brem H, Mahaley MS, Vick NA, Black KL, Schold SC, Burger PC, Friedman AH, Ciric IC, Eller TW, Cozzens JW, Kenealy JN: Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74:441-446, 1991.
8. Cavalier M, Benoit JP, Thies C: The formation and characterization of hydrocortisone-loaded poly((±)lactide) microspheres. J Pharm Pharmacol 38:249-253, 1986.
9. Frazza EJ, Schmidt EE: A new absorbable suture. J Biomed Mater Res 5:43-58, 1971.
10. Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30:907-911, 1980.
11. Hoshino T, Wilson CB: Cell kinetic analysis of human malignant brain tumor (gliomas). Cancer 44:956-962, 1979.
12. Judy KD, Olivi A, Buahin KG, Domb A, Epstein JI, Colvin M, Brem H: Effectiveness of controlled release of cyclophosphamide derivative with polymers against rat gliomas. J Neurosurgery 82:481-486, 1995.
13. Katakura R, Kuwahara K, Mori T: A newly devised tablet with prolonged release of bleomycin in brain tumors. Neurochirurgia [Suppl]:367, 1981 (abstr).
14. Kondziolka D, Lundsford LD, Claassen D, Pandalai S, Maitz AH, Flickinger JC: Radiobiology of radiosurgery: Part II - The rat C6 glioma model. Neurosurgery 31:280-288, 1992.
15. Kornblith PL, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68:1-17, 1988.
16. Kotsilimbas DG, Karpf R, Meredith S, Scheinberg LC: Evaluation of parenteral 5-FU on experimental brain tumors. Neurology 16:916-918, 1966.
17. Kubo O, Himuro H, Inoue N, Tajika Y, Tajika T, Tohyama T, Sakairi M, Yoshida M, Kaetsu I, Kitamura K: Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites. No Shinkei Geka 14:1189-1195, 1986.
18. Lawrence TS, Maybaum J: Fluoropyrimidines as radiation sensitizers. Semin Rad Oncol 3:20-28, 1993.
19. 14C and its metabolites in a murine glioma. J Natl Cancer Inst 49:1577-1584, 1972.
20. Levin VA, Edwards MS, Wara WM, Allen J, Ortega J, Vestnys P: 5-fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole and irradiation for brain stem gliomas: A pilot study of the brain tumor research center and the children cancer group. Neurosurgery 14:679-681, 1984.
21. Menei P, Benoit JP, Boisdron-Celle M, Fournier D, Mercier P, Guy G: Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres. Neurosurgery 34: 1058-1064, 1994.
22. Menei P, Croue A, Daniel V, Pouplard-Barthelaix A, Benoit JP: Fate and biocompatibility of three types of microspheres implanted into the brain. J Biomed Mater Res 28:1079-1085, 1994.
23. Menei P, Daniel V, Montero-Menei C, Brouillard M, Pouplard-Barthelaix A, Benoit JP: Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres. Biomaterials 14: 470-478, 1993.
24. Moore DH, Fowler WC, Crumpler LS: 5-Fluorouracil neurotoxicity: Case report. Gynecol Oncol 36:152-154, 1990.
25. Neuwelt EA, Barnett PA, Frenkel EP: Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: Observations on problems of drug delivery. Neurosurgery 14:154-160, 1984.
26. Oda Y, Uchida Y, Murata T, Mori K, Tokuriki Y, Handa H, Kobayashi A, Hashi K, Kieler J: Treatment of brain tumors with anticancer pellet: Experimental and clinical study. No Shinkei Geka 10:375-381, 1982.
27. Penn RD, Kroin JS, Harris JE, Chiu KM, Braun DP: Chronic intratumoral chemotherapy of a rat tumor with cisplatin and fluorouracil. Appl Neurophysiol 46:240-244, 1983.
28. Rama B, Mandel T, Jansen J, Dingeldein E, Mennel HD: The intraneoplastic chemotherapy in a rat brain tumour model utilizing methotrexate-polymethylmethacrylate-pellets. Acta Neurochir (Wien) 87:70-75, 1987.
29. Ringkjob R: Treatment of intracranial gliomas and metastatic carcinomas by local application of cytostatic agents. Acta Neurol Scand 44:318-322, 1968.
30. Ruiz JM, Benoit JP: In vivo peptide release from poly(D,L-lactic acid-co-glycolic acid) copolymer 50/50 microspheres. J Controlled Release 16:177-186, 1991.
31. Shapiro WR: Studies on the chemotherapy of experimental brain tumors: Evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine and 5-fluorouracil. J Natl Cancer Inst 46:359-368, 1971.
32. Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JC, Robertson JT, Mealey J, Ransohoff J, Mahaley MS: A randomized comparison of intra-arterial versus intravenous BCNU with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76:772-781, 1992.
33. Skipper HE, Schabel FF Jr, Trader MW: Experimental evaluation of potential anticancer agents: VI - Anatomical distribution of leukemic cells and failure of chemotherapy. Cancer Res 21:1154-1164, 1961.
34. Soloway AH, Mark VH, Dukat EG, Kjellberg RN: Chemotherapy of brain tumors: I - Transplanted murine ependymoblastomas. Cancer Chemother Rep 36:1-4, 1964.
35. Spenlehauer G, Veillard M, Benoit JP: Formation and characterization of cisplatin-loaded poly(D,L-lactide) microspheres for chemoembolization. J Pharm Sci 75:750-755, 1986.
36. Spenlehauer G, Vert M, Benoit JP, Boddaert A: In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials 10:557-563, 1989.
37. Tamargo RJ, Myseros JS, Epstein JI, Yang MB, Chasin M, Brem H: Interstitial chemotherapy of the 9L gliosarcoma: Controlled release polymers for drug delivery in the brain. Cancer Res 53:329-333, 1993.
38. Visscher GE, Robinson RL, Maulding HV, Fong JW, Pearson JE, Argentieri GJ: Biodegradation of and tissue reaction to 50:50 poly(D,L-lactide-co-glycolide) microcapsules. J Biomed Mater Res 19:349-365, 1985.
39. Wise DL, Fellman TD, Sanderson JE, Wentworth RL: Lactic/ glycolic acid polymers, in Gregoriadis G (ed): Drug Carriers in Biology and Medicine. London, Academic Press, 1979, pp 237-270.
40. Yang MB, Tamargo RJ, Brem H: Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer. Cancer Res 49:5103-5107, 1989.